Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BLCO

Bausch plus Lomb (BLCO)

Bausch plus Lomb Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:BLCO
DateTimeSourceHeadlineSymbolCompany
06/02/202523:00Business WireBausch + Lomb Provides Update on Potential SaleNYSE:BLCOBausch plus Lomb Corporation
22/01/202523:00Business WireBausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19NYSE:BLCOBausch plus Lomb Corporation
13/01/202523:00Business WireBausch + Lomb Bolsters Pipeline with Acquisition of Whitecap BiosciencesNYSE:BLCOBausch plus Lomb Corporation
13/01/202522:00Business WireBausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European UnionNYSE:BLCOBausch plus Lomb Corporation
07/01/202523:00Business WireBausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising ChallengeNYSE:BLCOBausch plus Lomb Corporation
02/01/202523:00Business WireBausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:BLCOBausch plus Lomb Corporation
27/12/202408:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
27/12/202408:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
27/12/202408:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
12/12/202423:00Business WireBausch + Lomb Responds to Rumors of a Potential SaleNYSE:BLCOBausch plus Lomb Corporation
11/12/202422:59Business WireBausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment CapabilitiesNYSE:BLCOBausch plus Lomb Corporation
14/11/202423:00Business WireBausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
02/11/202407:27Edgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
31/10/202407:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BLCOBausch plus Lomb Corporation
30/10/202422:04Edgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
30/10/202422:00Business WireBausch + Lomb Announces Third-Quarter 2024 ResultsNYSE:BLCOBausch plus Lomb Corporation
14/10/202422:00Business WireBausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular LensNYSE:BLCOBausch plus Lomb Corporation
09/10/202423:00Business WireBausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30NYSE:BLCOBausch plus Lomb Corporation
01/10/202421:00Business WireBausch + Lomb Launches Opal™ Digital Marketplace in the United StatesNYSE:BLCOBausch plus Lomb Corporation
17/09/202420:42IH Market NewsInvestors Anticipate Retail Sales Data and Fed Decision; Oil Prices Dip as Investors Weigh U.S. ProductionNYSE:BLCOBausch plus Lomb Corporation
07/08/202407:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
02/08/202406:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BLCOBausch plus Lomb Corporation
02/08/202406:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BLCOBausch plus Lomb Corporation
31/07/202421:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
31/07/202421:00Business WireBausch + Lomb Announces Second-Quarter 2024 ResultsNYSE:BLCOBausch plus Lomb Corporation
30/07/202409:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
30/07/202409:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
30/07/202409:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
12/07/202402:05Business WireBausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31NYSE:BLCOBausch plus Lomb Corporation
08/07/202421:00Business WireMillions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find ReliefNYSE:BLCOBausch plus Lomb Corporation
 Showing the most relevant articles for your search:NYSE:BLCO

Your Recent History

Delayed Upgrade Clock